Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1992Journal of Clinical Oncology

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.

View Full Paper
Ask AI
Bookmark
Share

Authors

DAD. Craig AllredUniversity of VermontGCGary M. ClarkDana-Farber Brigham Cancer CenterATAmol TandonUmeå University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Allred et al. (1992) studied this question.

synapsesocial.com/papers/6a0cd465c031bbff4134c4cehttps://doi.org/10.1200/jco.1992.10.4.599
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immunohistochemical Study on Overexpression of c‐erbB‐2 Protein in Human Breast Cancer: Its Correlation with Gene Amplification and Long‐term Survival of Patients1990 · 83 citations
  2. 2A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.1985 · 604 citations
  3. 3The neu Gene: an erb B-Homologous Gene Distinct from and Unlinked to the Gene Encoding the EGF Receptor1985 · 519 citations